§ Funding Round
Series A funding round for Ablaze Pharmaceuticals raising $75M in November 2021
Series A funding round for Ablaze Pharmaceuticals raising $75M in November 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
Vivo CapitalLEAD | Organization | — |
Advantech CapitalLEAD | — | — |
Nan Fung Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
Samsara BioCapital | — | — |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$75M
Top Valuation
-
Ablaze Pharmaceuticals raised $75M in a Series A round.
The round was announced on 11/01/21.
The round was led by Vivo Capital, Advantech Capital.
